Neurogene Inc. Other Non-Current Assets
Neurogene Inc. (NGNE) had Other Non-Current Assets of $1.11 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OtherAssetsNoncurrent · last filed 2026-08-11
- 2026-06-30: Other Assets, Noncurrent $1.11M.
- 2026-03-31: Other Assets, Noncurrent $1.08M.
- 2025-12-31: Other Assets, Noncurrent $1.03M.
- 2025-09-30: Other Assets, Noncurrent $1.06M.
| Period end | Other Assets, Noncurrent | Other Assets, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $1.11M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $1.08M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $1.03M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $1.06M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $1.10M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $896.00K 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $975.00K 10-K · filed 2026-03-24 | |
| 2024-09-30 | $789.00K 10-Q · filed 2024-11-18 | |
| 2024-06-30 | $794.00K 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $743.00K 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $764.00K 10-K · filed 2025-03-24 | |
| 2023-09-30 | $524.00K 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $529.00K 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $905.00K 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $0.00 10-K · filed 2024-03-18 | $936.00K 10-K · filed 2023-03-20 |
| 2022-09-30 | $1.91M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $2.02M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $1.95M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $1.93M 10-K · filed 2023-03-20 | |
| 2021-09-30 | $1.99M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $1.93M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $1.92M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $1.93M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $997.00K 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $1.13M 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $535.00K 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $30.00K 10-K · filed 2021-03-25 | |
| 2015-09-30 | $12.00K 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $12.00K 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $12.00K 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $13.00K 10-K · filed 2016-03-14 | $13.39K 10-K · filed 2015-03-16 |
| 2014-09-30 | $13.86K 10-Q · filed 2014-11-04 | |
| 2014-06-30 | $16.77K 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $135.34K 10-Q · filed 2014-05-13 | |
| 2013-12-31 | $277.29K 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |